Sign in

NCT05154513Completed

Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV

Source: ClinicalTrials.gov · Last updated 13 Jan 2026

Brief summary (registry, in English)

IMPAACT 2028 is an observational prospective study to characterize a cohort of early treated children who may participate in future research related to HIV remission or cure. Up to approximately 250 participants will be in the study for approximately seven years. No intervention is provided in the study.

Status (registry)
Completed
Study type
Observational
Enrollment
163 (actual)
First submitted
4 Mar 2021
Start date
2 Feb 2022
Primary completion date
30 Jul 2025
Lead sponsor
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Diseases
HIV
NCT number
NCT05154513

What you commit to

  • Study type: Observational
  • Participants enrolled: 163
  • From 2 Feb 2022 to the primary completion date, 30 Jul 2025
  • 28 sites in 11 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Has any documented or suspected clinically significant medical condition or any other condition that, in the opinion of the site investigator, would make participation in the study unsafe or otherwise interfere with completing study procedures

Who the study is looking for

  • Participated in one of the parent studies
  • Confirmed HIV-1 infection based on documented nucleic acid testing of two blood samples collected at different time points
  • Received early treatment for HIV-1 infection, defined as treatment with at least three ARV agents from at least two classes of ART, initiated within 12 weeks of birth
  • Based on parent or guardian report at entry, child is expected to be available for at least 24 months of follow-up
  • Parent or guardian is willing and able to provide written informed consent for child's study participation and, when applicable per institutional review board/ethics committee (IRB/EC) policies and procedures, child is willing and able to provide written assent for study participation

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (28)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
School of Medicine, University of Minas Gerais - FUNDEP (5073)
Coordinator of this site? Confirm its status
Belo HorizonteBrazilUnknown status
5071, Instituto de Puericultura e Pediatria Martagao Gesteira Clinical Research Site
Coordinator of this site? Confirm its status
Rio de JaneiroBrazilUnknown status
Hospital Geral De Nova Igaucu (5097)
Coordinator of this site? Confirm its status
Rio de JaneiroBrazilUnknown status
Hospital dos Servidores Rio de Janeiro
Coordinator of this site? Confirm its status
Rio de JaneiroBrazilUnknown status
Ribeirao Preto Medical School, University of Sao Paulo (5074)
Coordinator of this site? Confirm its status
São PauloBrazilUnknown status
Gaborone CRS 12701
Coordinator of this site? Confirm its status
GaboroneBotswanaUnknown status
Molepolole Prevention/Treatment Trials CRS 12702
Coordinator of this site? Confirm its status
MolepololeBotswanaUnknown status
Les Centres GHESKIO (30022)
Coordinator of this site? Confirm its status
Port-au-PrinceHaitiUnknown status
5121, Kenya Medical Research Institute/Walter Reed Project Clinical Research Center Kericho Clinical Research Site
Coordinator of this site? Confirm its status
KerichoKenyaUnknown status
College of Med. JHU CRS (30301)
Coordinator of this site? Confirm its status
BlantyreMalawiUnknown status
University of North Carolina Lilongwe (12001)
Coordinator of this site? Confirm its status
LilongweMalawiUnknown status
Siriraj Hospital Mahidol University CRS (5115)
Coordinator of this site? Confirm its status
BangkokThailandUnknown status
Chiang Rai Regional Hospital (5116)
Coordinator of this site? Confirm its status
Chiang RaiThailandUnknown status
Kilimanjaro Christian Medical Centre (5118)
Coordinator of this site? Confirm its status
MoshiTanzaniaUnknown status
-
Coordinator of this site? Confirm its status
KampalaUgandaUnknown status
5030, Emory University School of Medicine Clinical Research Site
Coordinator of this site? Confirm its status
AtlantaUnited StatesUnknown status
University of Colorado (5052)
Coordinator of this site? Confirm its status
AuroraUnited StatesUnknown status
5055, South Florida CDTC Fort Lauderdale Clinical Research Site
Coordinator of this site? Confirm its status
Fort LauderdaleUnited StatesUnknown status
5128, Texas Children's Hospital Clinical Research Site
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status
David Geffen School of Medicine at UCLA (CRS 5112)
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status
Univ of Miami Pediatric/Perinatal HIV/AIDS (5127)
Coordinator of this site? Confirm its status
MiamiUnited StatesUnknown status
-
Coordinator of this site? Confirm its status
DurbanSouth AfricaUnknown status
8051, Wits RHI Shandukani Research Centre Clinical Research Site
Coordinator of this site? Confirm its status
JohannesburgSouth AfricaUnknown status
Soweto IMPAACT CRS (8052)
Coordinator of this site? Confirm its status
JohannesburgSouth AfricaUnknown status
Family Clinical Research Unit (FAM-CRU) CRS (8950)
Coordinator of this site? Confirm its status
Tygerberg HillsSouth AfricaUnknown status
St. Mary's CRS 30303
Coordinator of this site? Confirm its status
ChitungwizaZimbabweUnknown status
Seke North CRS 30306
Coordinator of this site? Confirm its status
ChitungwizaZimbabweUnknown status
Harare Family Care (31890)
Coordinator of this site? Confirm its status
HarareZimbabweUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.